RenovoRx (RNXT) Stock Price, Quote, News & History

Comments

RenovoRx Inc (RNXT) Stock Price, Quote, News & History

RNXTNASDAQ

Trade with Public

$0.9015

-0.0113-1.24%

At close: Feb 20, 4:00 PM EST

$0.9105

-0.0023-0.25%

Pre-Market: 8:29 AM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$0.90

Volume / Avg.

576.00 / 239.68K

Day Range

- - -

52 Wk Range

0.70 - 1.45

Market Cap

$33.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.59%

Days to Cover

2.51

Recent RenovoRx Inc News

Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.38M

Investing Cash Flow (TTM)

-14.00K

Financing Cash Flow (TTM)

10.88M

Free Cash Flow (TTM)

-10.40M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

481.00K

Analyst Trends and Forecast

1

Aug 25

1

Nov 25

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$23.23M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

31.52

PB Ratio (TTM)

4.09

Earnings Yield % (TTM)

-39.93%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.22

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$10.04M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$0.90

Volume / Avg.

576.00 / 239.68K

Day Range

- - -

52 Wk Range

0.70 - 1.45

Market Cap

$33.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.59%

Days to Cover

2.51

About

Sector

Health Care

Industry

Biotechnology

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tra...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy RenovoRx (RNXT) stock?

A

You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are RenovoRx (RNXT) competitors?

A

Other companies in RenovoRx’s space includes: Kyntra Bio Inc (NASDAQ:KYNB), Outlook Therapeutics Inc (NASDAQ:OTLK), Atossa Therapeutics Inc (NASDAQ:ATOS), Palatin Technologies Inc (AMEX:PTN) and ABVC BioPharma Inc (NASDAQ:ABVC).

Q

What is the forecast, or price target, for RenovoRx (RNXT) stock?

A

RenovoRx has a consensus price target of $8.25.

Q

What is the current price for RenovoRx (RNXT)?

A

The stock price for RenovoRx (NASDAQ: RNXT) is $0.9105 last updated February 24, 2026 at 8:31 AM EST.

Q

Does RenovoRx (RNXT) pay a dividend?

A

There are no upcoming dividends for RenovoRx.

Q

When is RenovoRx (NASDAQ:RNXT) reporting earnings?

A

RenovoRx does not have any upcoming earnings scheduled.

Q

Is RenovoRx (RNXT) going to split?

A

There is no upcoming split for RenovoRx.

Q

What sector and industry does RenovoRx (RNXT) operate in?

A

RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Outlook Therapeutics Inc

NASDAQ:OTLK

$0.41

1.48%

Atossa Therapeutics Inc

PTN

OnKure Therapeutics Inc

NASDAQ:OKUR

$2.60

5.77%

AEON

Key Statistics

Open

-

Close

$0.90

Volume / Avg.

576.00 / 239.68K

Day Range

- - -

52 Wk Range

0.70 - 1.45

Market Cap

$33.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.59%

Days to Cover

2.51

Recent RenovoRx Inc News

Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.38M

Investing Cash Flow (TTM)

-14.00K

Financing Cash Flow (TTM)

10.88M

Free Cash Flow (TTM)

-10.40M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

481.00K

Analyst Trends and Forecast

1

Aug 25

1

Nov 25

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$23.23M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

31.52

PB Ratio (TTM)

4.09

Earnings Yield % (TTM)

-39.93%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.22

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$10.04M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$0.90

Volume / Avg.

576.00 / 239.68K

Day Range

- - -

52 Wk Range

0.70 - 1.45

Market Cap

$33.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

1.59%

Days to Cover

2.51

About

Sector

Health Care

Industry

Biotechnology

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tra...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry